Matinas BioPharma Cleared for Phase 1 Clinical Study of MAT2501 for the Treatment of Non-Tuberculous Mycobacterium Infections by FDA Biotech Investing
Amarantus Reports Issuance of Chinese Patent Covering Use of MANF for the Treatment of Parkinson's Disease Biotech Investing
